Inventor
HUDSON BILLY G
US30 patents
⚠️ This page may combine multiple inventors who share the name “HUDSON BILLY G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV KANSAS MEDICAL CENTER
15 patentsUS5567609AOct 22, 1996
Use of isolated domains of type IV collagen to modify cell and tissue interactions
UNIV KANSAS MEDICAL CENTER36 citations95
US6472411B1Oct 29, 2002
Advanced glycation end-product intermediaries and post-amadori inhibition
UNIV KANSAS MEDICAL CENTER19 citations91
US6472400B1Oct 29, 2002
Advanced gylcation end-product intermediaries and post-Amadori inhibition
UNIV KANSAS MEDICAL CENTER16 citations91
US6361994B1Mar 26, 2002
Method for inhibiting angiogenesis and tumors with the isolated NC1 α1 chain monomer of type IV collagen
UNIV KANSAS MEDICAL CENTER20 citations91
US6228858B1May 8, 2001
Advanced glycation end-product intermediaries and post-amadori inhibition
UNIV KANSAS MEDICAL CENTER24 citations91
US5856184AJan 5, 1999
Isolated domains of type IV collagen to modify cell and tissue interactions
UNIV KANSAS MEDICAL CENTER24 citations91
US5691182ANov 25, 1997
Use of isolated domains of type IV collagen to modify cell and tissue interactions
UNIV KANSAS MEDICAL CENTER20 citations91
US6440729B1Aug 27, 2002
Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen
UNIV KANSAS MEDICAL CENTER10 citations81
US6448222B1Sep 10, 2002
Use of isolated alpha 2 domain of type IV collagen to modify cell and tissue interactions
UNIV KANSAS MEDICAL CENTER3 citations72
US6432706B1Aug 13, 2002
Method for inhibiting angiogenesis and tumors with the isolated NC1 α6 chain monomer of type IV collagen
UNIV KANSAS MEDICAL CENTER6 citations72
US6419924B1Jul 16, 2002
Antibodies of isolated domains of type IV collagen modify cell interactions
UNIV KANSAS MEDICAL CENTER3 citations72
US6384012B1May 7, 2002
Use of isolated domains of type IV collagen to modify cell and tissue interactions
UNIV KANSAS MEDICAL CENTER7 citations72
US6498140B1Dec 24, 2002
Use of isolated domains of type IV collagen to modify cell and tissue interactions
UNIV KANSAS MEDICAL CENTER1 citations61
US6358735B1Mar 19, 2002
Method for inhibiting angiogenesis and tumors with the isolated NC1 α3 chain monomer of type IV collagen
UNIV KANSAS MEDICAL CENTER5 citations61
US6680293B2Jan 20, 2004
Use of isolated domains of type IV collagen to modify cell and tissue interactions
UNIV KANSAS MEDICAL CENTER0 citations51
KANSAS UNIVERSITY MEDICAL CT
8 patentsUS7030146B2Apr 18, 2006
Methods for treating diabetic neuropathy
KANSAS UNIVERSITY MEDICAL CT270 citations94
US6277558B1Aug 21, 2001
α-3 chain type IV collagen polynucleotides
KANSAS UNIVERSITY MEDICAL CT42 citations92
US6750209B1Jun 15, 2004
Advanced glycation end-product intermediaries and post-amadori inhibition
KANSAS UNIVERSITY MEDICAL CT29 citations91
US6716858B1Apr 6, 2004
Methods for inhibiting diabetic complications
KANSAS UNIVERSITY MEDICAL CT20 citations91
US6740668B1May 25, 2004
Methods for inhibiting diabetic complications
KANSAS UNIVERSITY MEDICAL CT23 citations88
US6730686B1May 4, 2004
Methods for inhibiting oxidative modification of proteins
KANSAS UNIVERSITY MEDICAL CT25 citations86
US6689746B2Feb 10, 2004
Use of isolated domains of type IV collagen to modify cell and tissue interactions
KANSAS UNIVERSITY MEDICAL CT3 citations72
US7122517B2Oct 17, 2006
Crystallized structure of type IV collagen NC1 domain hexamer
KANSAS UNIVERSITY MEDICAL CT6 citations54